Medicine and Dentistry
Prostate Cancer
100%
Metastasis Potential
100%
Homeobox
100%
Androgen Insensitivity Syndrome
100%
Prostate Tumor
50%
Mucin 1
50%
Protein Binding
50%
Membrane Protein
50%
Ubiquitin Protein Ligase E3
50%
Somatostatin Receptor 1
50%
Gastrulation
50%
DNA Topoisomerase (ATP Hydrolysing)
50%
Neoplasm
25%
Expression Analysis
25%
Fatty Acid
25%
Prostatectomy
25%
Prostate Cancer Cell Line
25%
Advanced Cancer
25%
Real-Time Polymerase Chain Reaction
25%
Enhancer Region
25%
Tumor-Related Gene
25%
Minichromosome Maintenance Protein 6
25%
Polycomb Repressive Complex 2
25%
Gleason Score
25%
Cyclin Dependent Kinase Inhibitor 2A
25%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen Insensitivity Syndrome
100%
Prostate Cancer
100%
Metastasis Potential
100%
Binding Protein
66%
Ubiquitin Protein Ligase E3
66%
DNA Topoisomerase (ATP Hydrolysing)
66%
Somatostatin Receptor 1
66%
Membrane Protein
66%
Prostate Tumor
66%
Mucin 1
66%
Fatty Acid
33%
Polycomb Repressive Complex 2
33%
Cyclin Dependent Kinase Inhibitor 2A
33%
Minichromosome Maintenance Protein 6
33%
Neoplasm
33%
Advanced Cancer
33%
Gleason Score
33%
Biochemistry, Genetics and Molecular Biology
Homeobox
100%
Binding Protein
50%
Membrane Protein
50%
Transmembrane Protein
50%
Ubiquitin-Conjugating Enzyme
50%
DNA Gyrase
50%
Gastrulation
50%
Somatostatin Receptor 1
50%
Real-Time Polymerase Chain Reaction
25%
Mucin
25%
Cell Cycle
25%
Gleason Score
25%
EZH2
25%
Tumor-Related Gene
25%
Expression Analysis
25%
Minichromosome Maintenance
25%
Cancer Cell
25%
Enhancer Region
25%
Polycomb Repressive Complex 2
25%
MUC1
25%
Elongase
25%